InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（12 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
12
T+90 胜率
0%
T+90 平均收益
-14.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Anish Bhatnagar, 董事长兼首席执行官. Director active across 1 company, notably Soleno Therapeutics INC. Aggregated, 20 filings have been recorded. Split: 1 buy · 12 sells. Total volume traded: €8.5m. History available since 21 January 2022. The latest transaction was filed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Anish Bhatnagar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
114,200 股0Common StockSEC:0001614821-26-000001:0
7,620 股@ US$49.953.7% 占其流量Common StockSEC:0001614821-25-000005:0
14,183 股@ US$65.969110.2% 占其流量Common StockSEC:0001415889-25-009290:0
53,900 股0Common StockSEC:0001415889-25-001932:0
10,077 股@ US$45.36565.2% 占其流量Common StockSEC:0001415889-25-000953:0
19,413 股@ US$49.335810.2% 占其流量Common StockSEC:0001415889-24-024658:0
30,262 股@ US$47.192615.1% 占其流量Common StockSEC:0001415889-24-022648:0
32,789 股@ US$45.476716.0% 占其流量Common StockSEC:0001415889-24-020943:0
850,000 股0Common StockSEC:0001415889-24-019807:0
4,198 股@ US$41.22171.9% 占其流量Common StockSEC:0001415889-24-019266:0
11,383 股@ US$41.12275.1% 占其流量Common StockSEC:0001415889-24-010241:0
2,527 股@ US$48.301.3% 占其流量Common StockSEC:0001415889-24-001925:0
150,000 股0Common StockSEC:0001209191-24-001174:0
51,205 股@ US$35.259819.7% 占其流量Common StockSEC:0001209191-23-058577:0
4,000 股@ US$4.500.2% 占其流量Common StockSEC:0001209191-23-058575:0
27,716 股@ US$28.65198.5% 占其流量Common StockSEC:0001209191-23-057318:0
21,220 股@ US$27.02626.2% 占其流量Common StockSEC:0001209191-23-057034:0
160,602 股0Common StockSEC:0001209191-23-032691:0
60,000 股Common StockSEC:0000899243-22-013312:0
标准退出：2022年6月29日 (T+90)
39,033 股@ US$0.3730.1% 占其流量Common StockSEC:0000899243-22-003186:0
20 条申报中的 20 条
About Anish Bhatnagar
Anish Bhatnagar is President and Chief Executive Officer and Chief Executive Officer at Soleno Therapeutics INC (XNAS). Across 20 filings in total, the 20 sampled filings between 2022-01-25 and 2026-01-23 show 0 in buys and 8469857 in sells, with the dominant transaction nature indicated as sale.
